Survey likely to be tabled in July by the new government.
Move follows a spate of international regulatory enforcements on Indian drug firms.
Importers protest as food safety regulator demands adherence to recent law on labelling, blocks entry at ports for packs with stickers.
Govt wants firms to remove suffixes & prefixes to original names of these drugs.
The Indian Pharmaceutical Alliance has approached regulator for a dialogue to understand the concern raised by it
Say heavy penalties for medical errors might raise health care costs and make practitioners too cautious, says Sushmi Dey
Govt floated import tender, allowed import without fumigation.
As many as 150 applications are stuck at evaluation stage, says official.
According to a senior Planning Commission official, according to the new criteria evolved by members Abhijit Sen and Mihir Shah, henceforth BRGF amounts will be allocated on the basis of backward blocks and not just districts.
Ranbaxy's US factory, Ohm Laboratories, is learnt to have got a clean chit from the American regulator. This US facility was under surveillance of the Food and Drug Administration (FDA) since the end of 2012.
Happy hours, a discount concept popular across bars, restaurants and multiplexes, is now catching up in the health care sector, too.
The country's drug companies have attracted the highest number of enforcements from the American drug regulator in 2013, a year that has seen the US Food and Drug Administration turning stricter to ensure compliance levels and quality of medicines.
DCGI, health ministry initiate dialogues with foreign regulators, try to understand global best practices
As the country faces the possibility of a fractured mandate after the 2014 general elections, Planning Commission Deputy Chairman Montek Singh Ahluwalia is of the view that in an era of coalition governments, special steps are needed to build consensus around policies or else, India will not be able to grow at its full potential.
The move comes in the wake of many facilities of Ranbaxy in India being barred by the US Food and Drugs Administration for supplying medicines to the US.
Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter
For the past few weeks, the government has been in an overdrive, pushing stuck projects with the larger aim to improve the country's economic growth, which had fallen to a four-year low of 4.4 per cent in the first quarter of this financial year.
.jpg)
Ledger entries in NSEL books show no record of T+2 leg of the paired trades with borrowers.
Medicines, including antibiotics, contraceptives and anti-diabetic drugs, were found to be out of stock at various places around Delhi.
In the past two decades, the country's economic growth slipped below five per cent in only three years - in 1997-98, 2000-01 and 2002-03.
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances